docetaxel-HPG (STK-01)
/ Sitka Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 11, 2021
[VIRTUAL] STK-012, an alpha/beta selective IL-2 mutein for the activation of the antigen-activated T cells in solid tumor
(AACR 2021)
- "STK-012 selectively induced memory T cell expansion, including CD28+ CD95+ CD8 T cells. In summary, STK-012 avoids IL-2 mediated toxicity and may enable the specific expansion of antigen activated memory T cells in cancer patients, leading to durable tumor response."
IO biomarker • Oncology • Solid Tumor • CD22 • CD8 • FAS • FCGR2A • FCGR2B • IL2 • STAT5
1 to 1
Of
1
Go to page
1